Role of the Akt Pathway in Prostate Cancer

被引:20
|
作者
de Souza, Paul L. [1 ,2 ]
Russell, Pamela J. [2 ,3 ]
Kearsley, John [2 ]
机构
[1] St George Hosp, Canc Pharmacol & Therapeut Lab, Sch Clin, Kogarah, NSW 2217, Australia
[2] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia
[3] Prince Wales Hosp, Oncol Res Ctr, Randwick, NSW 2031, Australia
关键词
Signal transduction; cell signalling; apoptosis; chemoresistance; cancer progression; TUMOR-SUPPRESSOR GENE; PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; ANDROGEN RECEPTOR EXPRESSION; NF-KAPPA-B; PHENOXODIOL-INDUCED APOPTOSIS; IN-VITRO; CELL-SURVIVAL; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; MOLECULAR ALTERATIONS;
D O I
10.2174/156800909787581006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Akt pathway, or more accurately, network, has assumed increasing importance with the understanding that it represents a key role in cancer cell survival and proliferation. Intense efforts to target proteins and enzymes within this pathway with highly selective compounds have led to the development of diverse agents now in Phase I-III clinical trials. Moreover, the notion that exploitation of multiple "druggable" targets simultaneously or in the appropriate sequence may provide better anti-tumour effects than single drugs hold promise that chemoresistance may be overcome, at least in part. This paper reviews important aspects of the Akt network, with a particular focus on prostate cancer biology.
引用
收藏
页码:163 / 175
页数:13
相关论文
共 50 条
  • [1] The emerging role of the PI3-K-Akt pathway in prostate cancer progression
    L Li
    M M Ittmann
    G Ayala
    M-J Tsai
    R J Amato
    T M Wheeler
    B J Miles
    D Kadmon
    T C Thompson
    Prostate Cancer and Prostatic Diseases, 2005, 8 : 108 - 118
  • [2] The emerging role of the PI3-K-Akt pathway in prostate cancer progression
    Li, L
    Ittmann, MM
    Ayala, G
    Tsai, MJ
    Amato, RJ
    Wheeler, TM
    Miles, BJ
    Kadmon, D
    Thompson, TC
    PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (02) : 108 - 118
  • [3] Dual inhibition of autophagy and the AKT pathway in prostate cancer
    Lamoureux, Francois
    Zoubeidi, Amina
    AUTOPHAGY, 2013, 9 (07) : 1119 - 1120
  • [4] Targeting the Akt pathway and HDAC signaling in prostate cancer
    Paesante, Silvia
    Miles, Marie Kiersten
    Nguyen, Holly
    Vessella, Robert
    Pili, Roberto
    CANCER RESEARCH, 2011, 71
  • [5] The role of the sarcosine pathway in prostate cancer progression
    Khan, Amjad P.
    Rajendiran, Thekkelnaycke M.
    Ateeq, Bushra
    Asangani, Irfan
    Yocum, Anastasia K.
    Mehra, Rohit
    Sreekumar, Arun
    Chinnaiyan, Arul M.
    CANCER RESEARCH, 2011, 71
  • [6] Phosphorylation of LIFR promotes prostate cancer progression by activating the AKT pathway
    Shao, Jialiang
    Zhu, Wencheng
    Ding, Yufeng
    Zhu, Hongwen
    Jing, Xiaoqian
    Yu, Hua
    Lu, Mujun
    Qiao, Yunbo
    Wang, Xiang
    Ai, Hua
    Wang, Xiongjun
    CANCER LETTERS, 2019, 451 : 110 - 121
  • [7] Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway
    De Velasco, Marco A.
    Uemura, Hirotsugu
    ADVANCES IN UROLOGY, 2012, 2012
  • [8] The PI3K/AKT pathway in the pathogenesis of prostate cancer
    Chen, Huixing
    Zhou, Lan
    Wu, Xiaorong
    Li, Rongbing
    Wen, Jiling
    Sha, Jianjun
    Wen, Xiaofei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 1084 - 1091
  • [9] Akt in prostate cancer: Possible role in androgen-independence
    Ghosh, PM
    Malik, S
    Bedolla, R
    Kreisberg, JI
    CURRENT DRUG METABOLISM, 2003, 4 (06) : 487 - 496
  • [10] Biological Role of AKT and Regulation of AKT Signaling Pathway by Thymoquinone: Perspectives in Cancer Therapeutics
    Junaid, Md
    Akter, Yeasmin
    Afrose, Syeda Samira
    Tania, Mousumi
    Khan, Md Asaduzzaman
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (03) : 288 - 301